STING1 and cancer: On one hand, cGAS-STING activating therapies can trigger an intended pro-inflammatory response to cancers, but it can potentially also initiate a cascade of autoimmunity and inflammation, which can be as devastating as the cancers these treatments were designed to circumvent.